Skip to main content
Clinical Trials/NL-OMON53657
NL-OMON53657
Recruiting
Not Applicable

Advanced MRI techniques and biomarkers to substitute gadolinium enhanced MRI for the detection of disease activity in multiple sclerosis. - ACTIVITY

Amsterdam UMC0 sites75 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Amsterdam UMC
Enrollment
75
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • To be eligible for this study, the participant must meet the following
  • Diagnosed as CIS, RRMS, PPMS based on McDonald criteria (2017\)
  • Adult (18\-70 years old)
  • Signed informed consent
  • Separate inclusion criteria will be applied for the active and inactive
  • For the active subgroup:
  • one or more Gd\-enhancing lesion on brain MRI or signs of clinical disease
  • For the inactive subgroup:
  • no Gd enhancing lesion on brain MRI and no clinical signs of disease activity.

Exclusion Criteria

  • A potential participant will be excluded from the study based on the following
  • contra\-indications for MRI
  • History of (psychiatric) disorder which causes the patient to be incompetent to
  • make a well\-informed decision
  • Other concurrent neurological disease

Outcomes

Primary Outcomes

Not specified

Similar Trials